This week, Fisher Scientific becomes the latest company to join the BCW Index. The firm, which completed its purchase of high-content screening firm Cellomics a couple of weeks ago, has been a competitor to several firms in the Index over the past couple of years through its RNAi and protein assay kits and reagents, and now will compete against others with its cell screening operations (see related article).

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.